Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This transcript is a non-coding RNA expressed from the DNA strand opposite to the ACOT6 gene, rendering it an "antisense" RNA. Such antisense transcripts are widely present in human genomes and can affect the expression and chromatin state of their corresponding sense gene. Mechanistically, antisense RNAs can mediate transcriptional interference (by colliding RNA polymerases), mask splicing or regulatory sequences in the sense transcript, form double-stranded RNA leading to degradation or RNA interference, or influence chromatin remodeling and histone modification[1][2]. In the case of the "novel transcript, antisense to ACOT6," no specific biological function, disease connection, or therapeutic target status has been established. It remains an annotated, but uncharacterized, non-coding RNA in genomic databases.
Transcriptional interference; RNA masking and possible modulation of epigenetic marks such as histone acetylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to acyl-CoA thioesterase 6.